|
|
| What's The Risk Of Letting Researchers Use LLMs? | Guest Column | A conversation with Jakob Alme, Sage Therapeutics | Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain. |
|
|
|
CLINICAL DATA MANAGEMENT & ANALYTICS |
|
|
| How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two | Guest Column | By Katherine Leibowitz and Catherine London, Leibowitz Law | Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI. |
|
|
| Responsible Use Of AI In Healthcare: Work In Progress | Article | By Stephanie Rosner, DIA; Martin Hodosi and Rosanna Lim, Kearney | Delve into the transformative role and potential benefits of Artificial Intelligence (AI) in healthcare and learn why it's crucial to carefully consider and plan for the responsible use of AI. |
|
|
|
|
| Risk-Based Quality Management | Product | Ergomed Clinical Research | Ergomed's proactive approach to managing clinical trials tackles clinical research complexity head-on. |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
